Research Topics
| H N IbrahimSummaryAffiliation: University of Minnesota Country: USA Publications
| Collaborators
|
Detail Information
Publications
Angiotensin II blockade in kidney transplant recipientsHassan N Ibrahim
Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, MN 55414, USA
J Am Soc Nephrol 24:320-7. 2013..99; P=0.05), but this finding requires validation. In conclusion, treatment with losartan did not lead to a statistically significant reduction in a composite of interstitial expansion or ESRD from IF/TA in kidney transplant recipients...
The search for an ideal screening test for chronic kidney diseaseHassan N Ibrahim
Divison of Renal Diseases and Hypertension, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
Am J Hypertens 19:615-6. 2006
The performance of three serum creatinine-based formulas in estimating GFR in former kidney donorsH N Ibrahim
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, Minnesota, USA
Am J Transplant 6:1479-85. 2006..In conclusion, the majority of former kidney donors have excellent kidney function and the MDRD formula should be the recommended GFR estimating model in this population...
Temporal trends in red blood transfusion among US dialysis patients, 1992-2005Hassan N Ibrahim
Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Am J Kidney Dis 52:1115-21. 2008..Studies addressing patterns and trends in red blood cell transfusion use in US hemodialysis patients surprisingly have received little attention in the last decade...
Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocolHassan Ibrahim
Division of Renal Diseases and Hypertension, Department of Surgery, University of Minnesota, Minneapolis, MN, USA
Transplantation 81:214-9. 2006..The risk of recurrence of glomerulonephritis in kidney transplant recipients on a steroid-free maintenance immunosuppression protocol is unknown...
Long-term consequences of kidney donationHassan N Ibrahim
Department of Medicine, University of Minnesota, Minneapolis 55414, USA
N Engl J Med 360:459-69. 2009..Previous studies have included relatively small numbers of donors and a brief follow-up period...
Pregnancy outcomes after kidney donationH N Ibrahim
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA
Am J Transplant 9:825-34. 2009....
Appraisal of GFR-estimating equations following kidney donationMeghan Sebasky
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN 55414, USA
Am J Kidney Dis 53:1050-8. 2009..It is not clear which serum creatinine-based glomerular filtration rate (GFR)-estimating model performs best in kidney donors...
An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetesHassan Ibrahim
Division of Renal Diseases and Hypertension, School of Public Health, University of Minnesota, Minneapolis, MN, USA
J Am Soc Nephrol 16:1051-60. 2005..A substantial variability in the estimates, however, remained...
Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and olderHassan N Ibrahim
Minneapolis Medical Research Foundation, Minneapolis, MN, USA
Nephrol Dial Transplant 24:3138-43. 2009..Their impact on transfusion frequency in elderly chronic kidney disease (CKD) patients aged 65 years and older with non-dialysis-dependent CKD has not been studied...
Diabetes after kidney donationH N Ibrahim
Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Am J Transplant 10:331-7. 2010....
Aldosterone in renal diseaseHassan N Ibrahim
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis 55455, USA
Curr Opin Nephrol Hypertens 12:159-64. 2003..Studying mediators of progression other than angiotensin II is therefore extremely important. The emerging role of aldosterone in progression of renal disease and the utility of its antagonism is discussed here...
GFR-estimating models in kidney transplant recipients on a steroid-free regimenAleksandra Kukla
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA
Nephrol Dial Transplant 25:1653-61. 2010..How to best estimate glomerular filtration rate (GFR) in kidney transplant recipients on steroid-free immunosuppression has not been established...
Weight loss: a neglected intervention in the management of chronic kidney diseaseHassan N Ibrahim
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, Minnesota 55414, USA
Curr Opin Nephrol Hypertens 19:534-8. 2010..The purpose of this review is to examine the impact of treatment of obesity on renal outcomes...
Blood transfusions in kidney transplant candidates are common and associated with adverse outcomesHassan N Ibrahim
Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Clin Transplant 25:653-9. 2011..These data demonstrate that transfusions remain common and confirm the adverse association between transfusions and PRA, and high PRA and inferior graft and patient outcomes...
Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney modelH N Ibrahim
Department of Medicine, University of Minnesota, Minneapolis, USA
J Am Soc Nephrol 11:625-31. 2000..In this model, reduction in nephron number is also critical in promoting hypertension in conjunction with hyperaldosteronism...
Aldosterone in renal diseaseT H Hostetter
University of Minnesota, Division of Renal Diseases and Hypertension, Minneapolis 55455, USA
Curr Opin Nephrol Hypertens 10:105-10. 2001..Aldosterone as well as angiotensin II thus appears to be instrumental in sustaining the hypertension and fibroproliferative destruction of the residual kidney...
Aldosterone in progressive renal diseaseT H Hostetter
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA
Semin Nephrol 21:573-9. 2001..Thus, aldosterone, as well as angiotensin II, appears to be instrumental in sustaining the hypertension and fibroproliferative destruction of the residual kidney...
Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantationM Canales
Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
Am J Transplant 6:2157-63. 2006..Based on this prevalence data and using GFR decay and death as study endpoints, we offer sample size estimates for a prospective, interventional trial that is aimed at slowing or preventing the progression of kidney disease...
A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donorsAbhinav Humar
Department of Surgery, University of Minnesota, Minneapolis, MN, USA
Am J Transplant 5:805-9. 2005..Mean time off work was 61.0 days for RL donors and 32.4 days for LLS donors (p = 0.004). RL donation is associated with greater operative stress for donors, but not necessarily with a more complicated recovery or differences in QOL...
Prednisone-free maintenance immunosuppression-a 5-year experienceArthur J Matas
Department of Surgery, University of Minnesota, Minneapolis, USA
Am J Transplant 5:2473-8. 2005..001), and fractures (p = 0.004). We conclude that prednisone-related side effects can be minimized in a protocol incorporating prednisone-free maintenance immunosuppression. Five-year graft outcome remains good...
Living or deceased donor kidney transplants for candidates with significant extrarenal morbidityRaja Kandaswamy
Department of Surgery, University of Minnesota, Minneapolis, 55455, USA
Clin Transplant 20:346-50. 2006..We found no difference in death-censored graft survival rates. CONCLUSION: Kidney transplant recipients with extrarenal morbidity benefit from an LD transplant. Both donor and recipient informed consent is important...
Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppressionRaja Kandaswamy
Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
Transplantation 83:722-6. 2007..However, in some recipients, the adverse effects of CNIs contribute to chronic allograft nephropathy and death with function--the two leading causes of late graft loss. Other recipients maintain stable graft function...
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decadesS J Taler
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
Am J Transplant 13:390-8. 2013..The fraction of older donors accepted with glucose intolerance or hypertension remains small and for the majority includes mild elevations in glucose or blood pressure that were previously classified as within normal limits...
Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc groupAndrew D Bostom
Department of Surgery, University of Minnesota, MMC-328 Mayo, Minneapolis 55455, USA
Am J Transplant 2:491-500. 2002
Serum uric acid and risk of ischemic stroke: the ARIC StudyAtsushi Hozawa
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, MN 55454-1015, USA
Atherosclerosis 187:401-7. 2006..08). CONCLUSION: Our findings suggest that UA is an independent predictor of ischemic stroke among subjects not using diuretics, but that elevated UA itself may not cause ischemic stroke...
Urinary beta2-microglobulin is associated with acute renal allograft rejectionWilliam S Oetting
Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
Am J Kidney Dis 47:898-904. 2006..This possibility must be confirmed in a larger cohort of kidney transplant recipients...
Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcomeArthur J Matas
Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
Transplantation 85:338-43. 2008..The benefits (e.g., low acute rejection [AR] rate) vs. the long-term risk of each immunosuppressive protocol may determine the protocol's value...
The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplantsAreef Ishani
Section of Nephrology, Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
Am J Kidney Dis 42:1275-82. 2003..The authors performed an analysis to determine whether higher renal function at transplant was associated with increased patient and graft survival rates...
Aldosterone in chronic kidney and cardiac diseaseThomas H Hostetter
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, USA
J Am Soc Nephrol 14:2395-401. 2003
Cystatin C is not superior to creatinine-based models in estimating glomerular filtration rate in former kidney donorsDaniel W Louvar
Division of Renal Diseases and Hypertension, Minneapolis, MN, USA
Transplantation 84:1112-7. 2007..Whether cystatin C is superior to creatinine-based estimates of GFR in those who have donated a kidney in the past has not been tested...
Studying multiple protein profiles over time to assess biomarker validityRaj S Kasthuri
University of Minnesota, Department of Medicine, MMC 480, 420 Delaware Street SE, Minneapolis, MN 55455, USA
Expert Rev Proteomics 3:455-64. 2006..The focus of this review is to illustrate the principle and value of serial protein profiling using a rapid protein extraction method...
Spontaneous subcapsular hematoma in chronic kidney diseaseRahul S Koushik
San Antonio Kidney Disease Center, San Antonio, TX 78217, USA
J Nephrol 19:391-3. 2006..The literature on spontaneous kidney hemorrhage in the modern imaging era is also reviewed...
Creatinine-based glomerular filtration rates and microalbuminuria for detecting metabolic abnormalities in US adults: the National Health and Nutrition Examination Survey 2003-2004Robert N Foley
United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
Am J Nephrol 28:431-7. 2008..This study aimed to quantify diagnostic test characteristics of these measures for detecting metabolic abnormalities...
Part 2. Going the distance... with renal diseaseMario Zarama
Kidney Specialists of Minnesota, USA
Nephrol News Issues 21:72-4. 2007
